BlackRock
LOXO

BlackRock’s Loxo Oncology, Inc LOXO Stock Holding History

BlackRock’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,280,968
Closed -$319M – 5123
2018
Q4 		$319M Buy
2,280,968
+9,540
+0.4% +$1.45M 0.02% 952
2018
Q3 		$388M Buy
2,271,428
+176,264
+8% +$29.6M 0.02% 947
2018
Q2 		$363M Buy
2,095,164
+280,475
+15% +$42.1M 0.02% 975
2018
Q1 		$209M Sell
1,814,689
-26,647
-1% -$2.83M 0.01% 1326
2017
Q4 		$155M Sell
1,841,336
-10,755
-0.6% -$897K 0.01% 1571
2017
Q3 		$171M Buy
1,852,091
+249,206
+16% +$19.4M 0.01% 1488
2017
Q2 		$129M Buy
1,602,885
+273,291
+21% +$15.1M 0.01% 1624
2017
Q1 		$55.9M Buy
1,329,594
+1,328,061
+86,632% +$54.7M ﹤0.01% 2147
2016
Q4 		$49K Sell
1,533
-33
-2% -$846 ﹤0.01% 2947
2016
Q3 		$41K Buy
1,566
+851
+119% +$22.3K ﹤0.01% 3066
2016
Q2 		$17K Buy
715
+394
+123% +$9.81K ﹤0.01% 3313
2016
Q1 		$9K Buy
+321
New +$6.72K ﹤0.01% 3220

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

BlackRock's LOXO Position: Q1 2019 in Review

BlackRock sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 2,280,968 shares — an estimated $319M sold.

BlackRock first reported a position in LOXO in Q1 2016 and held it in 12 quarters. The position peaked at $388M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • BlackRock reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • BlackRock sold 2,280,968 Loxo Oncology, Inc shares in Q1 2019, an estimated $319M.
  • BlackRock first reported a position in Loxo Oncology, Inc in Q1 2016 and held it in 12 quarters.
  • BlackRock's Loxo Oncology, Inc position peaked at $388M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on BlackRock's 13F filing for Q1 2019, filed 9 May 2019.